An attempt to prevent or delay denervation changes in rat muscles

Area of Science:

• Biochemistry
• Neuroscience
• Pharmacology

Background:

• Muscle denervation leads to significant physiological and biochemical changes.
• Lysosomes play a crucial role in cellular degradation and remodeling.
• Understanding lysosomal function is key to developing therapeutic strategies for muscle disorders.

Purpose of the Study:

• To evaluate the efficacy of lysosome-affecting drugs in preventing or delaying denervation-induced muscle changes in rats.
• To identify specific drugs that can mitigate the pathological consequences of muscle denervation.

Main Methods:

• Administration of various drugs known to affect lysosomal activity to denervated rat limbs.
• Monitoring electromyographic parameters, including the occurrence of fibrillations.
• Assessing muscle fiber diameters and analyzing acid phosphatase and acetylcholinesterase activity and distribution in end plates.

Main Results:

• Different drugs exhibited varying effects on the measured parameters.
• Chloroquin, thiouracil, and streptomycin demonstrated notable effectiveness in inhibiting denervation changes.
• Significant differences were observed between denervated and non-denervated limbs across treatment groups.

Conclusions:

• Lysosome-modulating drugs can potentially delay or inhibit muscle denervation changes.
• Chloroquin, thiouracil, and streptomycin represent promising therapeutic agents for managing denervation-related muscle atrophy.
• Further research is warranted to explore the clinical applications of these findings.